The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DEPECA-1 (Defeating Penile Cancer 1): A phase II study to evaluate a first-line systemic therapy with enfortumab vedotin plus avelumab for advanced and metastatic penile carcinoma.
 
Igor Tsaur
Consulting or Advisory Role - Johnson & Johnson
Research Funding - Astellas Pharma (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ipsen; Janssen Cilag AG; Merck
 
Maria Luisa Barcena
No Relationships to Disclose
 
You-Shan Feng
No Relationships to Disclose
 
Lennert Eismann
No Relationships to Disclose
 
Christian Thomas
No Relationships to Disclose
 
Christiane Gäbel
No Relationships to Disclose
 
Daniel Mueller
No Relationships to Disclose
 
Salah-Eddin Al-Batran
Stock and Other Ownership Interests - Frankfurter Institut für Klinische Krebsforschung IKF GmbH
Consulting or Advisory Role - Bristol-Myers Squibb; Eli Lilly Germany; Merck Sharp & Dohme
Speakers' Bureau - MCI Group
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Eurozyto (Inst); Federal Ministry of Education and Research (Inst); German Cancer Aid (Inst); German Research Foundation (Inst); Immutep (Inst); Ipsen (Inst); Lilly (Inst); MSD Sharp & Dohme (Inst); Roche (Inst); Sanofi (Inst); Vifor Pharma (Inst)
 
Anita Thomas
No Relationships to Disclose
 
Angelika Borkowetz
No Relationships to Disclose
 
Benjamin Meister
Honoraria - Sanofi Aventis GmbH
 
Marco Schnabel
Stock and Other Ownership Interests - BioNTech SE; Newron Pharmaceuticals
Honoraria - Apogepha; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Johnson & Johnson/Janssen; Medac; Merck Serono; MSD Oncology; Novartis; Pfizer
Consulting or Advisory Role - ACOUSIA; Astellas Pharma; AstraZeneca; Bayer; Gilead Sciences; Ipsen; Johnson & Johnson/Janssen; MSD Oncology; Novartis; Pfizer
Research Funding - ACOUSIA (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Ipsen (Inst); Johnson & Johnson/Janssen (Inst); Merck (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Ipsen; Johnson & Johnson/Janssen; Pfizer
 
Margitta Retz
Consulting or Advisory Role - Astellas Pharma
Research Funding - Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma
 
Maximilian Reimann
No Relationships to Disclose
 
Maria De Santis
Honoraria - AAA HealthCare; Accord Healthcare; Amgen; Astellas Pharma; AstraZeneca/MedImmune; Basilea; Bayer; BioClin Therapeutics; Bristol-Myers Squibb; Exelixis/Ipsen; Ferring; Gilead Sciences; Immunomedics; Ipsen; Janssen-Cilag; Merck Serono; Merck Sharp & Dohme; MSD Oncology; Novartis; Orion; Pfizer; Roche/Genentech; Sandoz-Novartis; Sanofi; Seagen; Thermosome
Consulting or Advisory Role - AAA HealthCare; Accord Healthcare; Amgen; Astellas Pharma; AstraZeneca; Basilea; Bayer; BioClin Therapeutics; BioSyn Healthy Pharma; Bristol-Myers Squibb; Eisai; Ferring; Gilead Sciences; GlaxoSmithKline; Immunomedics/Gilead; Ipsen; Janssen; Johnson & Johnson/Janssen; Merck Sharp & Dohme; Novartis; Orion Health; Roche/Genentech; Sandoz-Novartis; Sanofi; Seagen; Takeda; Thermosome
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Ipsen; Janssen; Johnson & Johnson/Janssen; Merck Serono; Pfizer; Roche; Roche/Genentech; Sanofi
 
Guenter Niegisch
Honoraria - Astellas Pharma; AstraZeneca; BMS GmbH & Co. KG; Eisai Germany; Ipsen; Janssen Oncology; Medac; Merck KGaA; MSD; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen Oncology; Merck/Pfizer; Pfizer; Roche Pharma AG
Travel, Accommodations, Expenses - AstraZeneca; Janssen Oncology; Roche
 
Eva Erne
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen; Merck; Pfizer
 
Steffen Rausch
Honoraria - Advanced Accelerator Applications; Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb/Sanofi; Ipsen; Janssen; Merck; Merck/Pfizer; Novartis
Consulting or Advisory Role - Ambu; AstraZeneca; Bayer; Bristol-Myers Squibb/Sanofi; Eisai; Ipsen; Lilly; Merck Serono; Merck/Pfizer
Speakers' Bureau - Bayer
Research Funding - Ambu
Travel, Accommodations, Expenses - Bayer; ipsen; Janssen; Merck/Pfizer